Veriheal

AUGUST 12, 2021

Patients who suffer from epilepsy , which affects some 3.4 This is according to a recently published study featured in the peer-reviewed journal Epilepsy & Behavior. This is according to a recently published study featured in the peer-reviewed journal Epilepsy & Behavior. CBD, which constitutes a $2,770.8

Epilepsy 68

Epilepsy Pharmaceutical Patients Sleep 68

United Patients Group

JANUARY 30, 2023

The Benefits of Cannabis in the Treatment of Myasthenia Gravis Introduction Myasthenia gravis ( MG ) is a rare autoimmune disease that affects the nerves and muscles. Doctors usually treat MG with thymectomies, immunomodulating drugs, acetylcholinesterase inhibitors and IV immunoglobulin treatments. Could marijuana be the answer?

Treatment 120

Treatment Cannabinoids Blood Pressure THC 120

MMJ Recs

NOVEMBER 20, 2023

Epilepsy Management: CBD, in particular, has emerged as an effective treatment for epilepsy, especially in individuals with rare and severe forms of the condition. Neurological Disorders: Several cannabinoids show promise in the treatment of neurological disorders, including multiple sclerosis (MS) and Parkinson’s disease.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

MMJ Recs

MARCH 28, 2024

Navigating the world of medical marijuana (MMJ) in Iowa can be a daunting task for patients seeking alternative treatments. From researching qualified doctors to scheduling appointments and discussing treatment options, we provide practical insights and tips to help patients confidently navigate this journey.

Patients 52

Patients Treatment Research and Development Therapy 52

CannaMD

MARCH 29, 2023

Florida law allows eligible residents to receive medical marijuana treatment for specific medical issues, including ALS, cancer, Crohn’s Disease, Epilepsy, Glaucoma, HIV/AIDS, Multiple Sclerosis, Parkinson’s Disease, PTSD, and more.

Patients 81

Patients Epilepsy Marijuana Treatment 81

Veriheal

JULY 26, 2023

Georgia medical cannabis patients will soon have greater access to treatment as cannabis oil will be sold in many more pharmacies. Eligible patients registered with the state’s Department of Public Health can purchase cannabis oil from Georgia’s independent pharmacies.

Oil 98

Oil Patients Access THC 98

NORML

JULY 12, 2021

The lawsuit, which was filed by a 19-year-old patient who uses cannabis for the treatment of severe epilepsy, argues that the proposed changes will unduly restrict medical cannabis access among patients and will discourage physicians from participating in the program.

Epilepsy 238

Epilepsy Legalization Treatment Patients 238

MMJ Recs

JUNE 11, 2020

Can medical marijuana treat epilepsy? This is an important question that needs to be thoroughly explored by any patient or carer of a person with epilepsy. Epilepsy is a serious medical condition that can be dangerous if not properly treated. Is epilepsy a qualifying condition for a medical marijuana card?

Epilepsy 52

Epilepsy Marijuana Treatment Conditions 52

Veriheal

FEBRUARY 21, 2023

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. How Do MMJ Restrictions Affect Patients and Doctors?

Access 98

Access Patients Chronic Pain Conditions 98

Medical Marijuana Program Connection

JANUARY 10, 2024

In a survey study of patients with either Lennox-Gastaut syndrome (LGS) or Dravet syndrome (DS), findings showed that treatment with add-on cannabidiol (CBD; Epidiolex) led to improvements in nonseizure outcomes, regardless of reduction in seizure frequency.

Epilepsy 45

Epilepsy CBD Treatment Patients 45

MMJ Recs

DECEMBER 13, 2023

While the state has traditionally held a conservative stance on cannabis, there has been a gradual shift in public opinion and legislative action, paving the way for a more inclusive and patient-centric approach to healthcare. Additionally, patients must have exhausted all other available treatment options without finding relief.

Dispensary 52

Dispensary Patients Marijuana Epilepsy 52

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

DECEMBER 11, 2021

A Manchester MP’s bid to open up cannabis treatments on the NHS has been blocked by Tory backbenchers in the House of Commons. 'A Despite the Government legalising medicinal cannabis in 2018, following a number of high-profile campaigns, thousands of people are still being denied access to the treatment.

Treatment 52

Treatment Access Patients Medicine 52

MMJ Recs

APRIL 1, 2024

We’re exploring the world of CBD, uncovering the benefits of CBD in medical marijuana, its impact on health, its potential as a treatment option, and what you need to know about its use in medical marijuana. CBD: A Promising Treatment Option One of the most compelling aspects of CBD is its versatility as a treatment option.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

MMJ Recs

DECEMBER 28, 2023

In recent years, a significant shift has occurred in the perception of medical marijuana, transforming it from a controversial substance to a recognized and, in some places, a legal form of medical treatment. Medical cannabis, with its anxiolytic properties, offers a potential solution.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

United Patients Group

JULY 7, 2023

3) Helps Manage Nausea and Vomiting Medical cannabis can be used to manage nausea and vomiting associated with chemotherapy, radiation therapy, and other medical treatments. Nausea and vomiting are common side effects of these treatments and can significantly impact a person’s quality of life.

Chronic Pain 105

Chronic Pain Sleep Epilepsy Conditions 105

Cannabis Law Report

AUGUST 23, 2022

A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. Qualifying conditions include anxiety disorders, severe chronic pain and epilepsy.

Data 52

Data Treatment Patients Chronic Pain 52

MMJ Recs

SEPTEMBER 19, 2023

In this article, we’ll explore the various chronic pain treatment options in Missouri, highlight top-rated pain specialists in the state, and delve into some of the specific services available, such as non-surgical pain relief in Missouri. Finding effective treatment is crucial to improving your quality of life.

Chronic Pain 52

Chronic Pain Patients Treatment Therapy 52

MMJ Recs

OCTOBER 2, 2023

California has been a trailblazer in the realm of medical marijuana, offering patients access to a variety of treatment options. Patients must first schedule an appointment with a licensed medical professional who can evaluate their medical history and condition. In 1996, the state became the first in the U.S.

Dispensary 52

Dispensary Patients Environment Conditions 52

Veriheal

MARCH 2, 2024

In December of 2023, the country recently made a new move towards reform that could stimulate the cannabidiol (CBD) industry and provide many patients, such as those with epilepsy , with access to potentially life-changing medical treatments. and Europe to treat severe epilepsy, as well as other medical conditions.

Legalization 106

Legalization Epilepsy Clinical Trials THC 106

MMJ Recs

MARCH 2, 2024

In Ohio, accessing medical marijuana involves more than just obtaining a prescription; it requires navigating a complex landscape of dispensaries, regulations, and patient expectations. This guide aims to demystify the process, offering practical advice and insights to help patients make informed decisions.

Dispensary 52

Dispensary Patients Marijuana Education 52

LifeCannMD

FEBRUARY 27, 2024

The Science Behind Medical Marijuana and Its Effects on Epileptic Seizures Medical Marijuana has garnered significant attention for its benefits in treating epilepsy and seizures. The most compelling evidence of the effectiveness of Medical Marijuana in treating epilepsy comes from clinical trials.

Clinical Trials 59

Clinical Trials Epilepsy Marijuana Research and Development 59

United Patients Group

AUGUST 1, 2023

Many studies have also suggested that medical cannabis has potential as a treatment for opioid addiction, as it can help alleviate withdrawal symptoms and reduce the risk of relapse. Overall, the benefits of medical cannabis in pain management are numerous and increasingly recognized by medical professionals and patients alike.

Epilepsy 52

Epilepsy Sleep Chronic Pain Research and Development 52

MMJ Recs

MAY 15, 2022

This initial MMJ legislation only allowed patients suffering from intractable epilepsy to use cannabis oil. In 2020, the law changed to allow patients with any medical condition to receive a doctor’s recommendation to use and purchase medical marijuana products containing a maximum 10 milligrams of THC.

Patients 52

Patients Marijuana Pharmaceutical Dispensary 52

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

In either case, there is definitely a connection, and the widening availability for adults to consume cannabis legally for recreational and medicinal purposes has driven public interest into using cannabis for mental health treatment. Between CBD and THC, CBD seems to hold the best potential as a treatment for anxiety compared to THC.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Leafwell

JANUARY 14, 2021

Cannabis derived treatments for persistent health conditions ranging from anxiety to insomnia, chronic pain to nausea have been hailed as a medical miracle of the modern age. One group of patients needs that medical.

Epilepsy 52

Epilepsy Chronic Pain Therapy Treatment 52

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

SEPTEMBER 28, 2021

In this case, the patient needs to look for the best ways to treat pain and improve their life quality. Acupuncture is one of the safest alternative forms of treatment for chronic pain. Ideally, it should be used in combination with other therapies, such as herbal medicine and massage, and can be a great addition to other treatments.

Treatment 52

Treatment Chronic Pain Therapy Tincture 52

Cannabis Law Report

SEPTEMBER 29, 2022

Australia’s drugs regulator issues 73 infringement notices over claims prescriptions could treat conditions such as cancer and epilepsy. It is also alleged that the unlawful advertising included unapproved references to the treatment of serious diseases or conditions, including in some cases cancer and epilepsy.

Epilepsy 52

Epilepsy Conditions Media Medicine 52

Otherside Farms

JANUARY 24, 2019

One area which is now widely talked about is how marijuana treats epilepsy. Marijuana in treatment of epilepsy. Epilepsy is a neurological condition which causes one to have seizures. Some of the treatments methods which are available also might not help some people with types of epilepsy that are resistant to drugs.

Epilepsy 40

Epilepsy Marijuana Oil Conditions 40

MMJ Recs

AUGUST 24, 2022

If there’s one thing the best pain management centers in Missouri all have in common, it’s that they’ll consider medical marijuana as a treatment! If you have a qualifying medical condition , MMJ could be a great treatment option for you. If you have a qualifying medical condition , MMJ could be a great treatment option for you.

Chronic Pain 52

Chronic Pain Patients Treatment Conditions 52

MMJ Recs

MARCH 30, 2022

Recently, patient drives in Pennsylvania have made MMJ cards accessible to a lot of PA residents. Patient Drives In Pennsylvania. Pennsylvania patient drives have helped thousands of people to avail of MMJ treatment in PA. But what are Pennsylvania patient drives? What Are Pennsylvania Patient Drives?

Patients 52

Patients Dispensary Events Treatment 52

MMJ Recs

APRIL 11, 2024

West Virginia has emerged as a trailblazer in the realm of medical marijuana, implementing a comprehensive program to provide patients with access to this therapeutic treatment option. To qualify for the West Virginia medical marijuana program, patients must have a qualifying medical condition as defined by state law.

Law 52

Law Programs Patients Conditions 52

Veriheal

MARCH 1, 2021

However, the number of states that will authorize qualified patients from out-of-state medical marijuana programs is still relatively small. . Many places will either permit patients access to dispensaries and/or permit medical cannabis possession within a reasonable amount. Seizures, including those characteristic of epilepsy.

Patients 117

Patients Marijuana Concentrates Recreational 117

Cannabis Law Report

JULY 30, 2019

Cannabidiol-based treatment receives marketing approval from EMA. The cannabidiol-based treatment Epidiolex has won a positive recommendation for marketing approval from a European Medicines Agency (EMA) panel for use as an additional treatment for two types of seizures. Source: [link].

Epilepsy 40

Epilepsy Pharmaceutical Medicine Treatment 40

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Cannabis Law Report

DECEMBER 3, 2021

An analysis from continuous EEG recordings in 17 patients enrolled in the Phase 2 refractory status epilepticus (RSE) study demonstrated a substantial increase in the alpha/delta ratio immediately after the start of IV ganaxolone in 75% of patients. in patients continuing ganaxolone (n=38) and 33.3%

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52